Disease block
K50-K52 – Nichtinfektiöse Enteritis und Kolitis
- Chapter XI: Krankheiten des Verdauungssystems
15Decisions
30Patient groups
Added benefit by patient group
- Minor2
- Non-quantifiable1
- Not proven27
Diseases in this disease block
- K50 Crohn-Krankheit [Enteritis regionalis] [Morbus Crohn] 6 decisions
- K51 Colitis ulcerosa 10 decisions
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2025-11-20TremfyaGuselkumabNot proven: 2 of 2 patient groups
- 2025-11-20TremfyaGuselkumabMinor: 1 of 2 patient groupsNot proven: 1 of 2 patient groups
- 2025-09-04OmvohMirikizumabNot proven: 2 of 2 patient groups
- 2025-02-20SkyriziRisankizumabNot proven: 2 of 2 patient groups
- 2024-10-02VelsipityEtrasimodNot proven: 2 of 2 patient groups
- 2024-01-18OmvohMirikizumabNot proven: 2 of 2 patient groups
- 2023-10-19RinvoqUpadacitinibNot proven: 2 of 2 patient groups
- 2023-06-15SkyriziRisankizumabMinor: 1 of 2 patient groupsNot proven: 1 of 2 patient groups
- 2023-02-16RinvoqUpadacitinibNot proven: 2 of 2 patient groups
- 2022-09-01EntyvioVedolizumabNot proven
- 2022-06-16ZeposiaOzanimodNot proven: 2 of 2 patient groups
- 2022-05-19JyselecaFilgotinibNot proven: 2 of 2 patient groups
- 2019-02-21XeljanzTofacitinibNot proven: 2 of 2 patient groups
- 2018-11-22AlofiselDarvadstrocelNon-quantifiable
- 2015-01-08EntyvioVedolizumabNot proven: 4 of 4 patient groups
Data status: 2026-10-29